Ingredion reaffirmed its full-year 2026 adjusted earnings per share guidance of $10.30 to $10.90, reflecting the sale of its majority stake in the Pakistan business. The company reported second-quarter net sales of $1.85 billion, up 1% from the prior year, with Texture & Healthful Solutions volume growth accelerating to 7%. Ingredion also announced that Tate & Lyle shareholders approved its all-cash offer, and the transaction is expected to deliver $130 million of run-rate synergies by 2030 and greater than 15% adjusted EPS accretion in the first full calendar year post-acquisition. Adjusted operating income for the quarter was $258 million, while cash from operations for the full year is now anticipated to be between $700 million and $800 million. Capital expenditures are expected to range from $450 million to $490 million, with additional spend allocated to the Argo facility.
Ingredion IncorporatedReaffirms 2026 EPS guidance and reports Q2 results with volume growth.
Tate & Lyle PLCShareholders approved all-cash offer, expected to deliver synergies and EPS accretion.